Cell BioEngines
Biotechnology · Regenerative Medicine
Overview
A global cellular medicine company headquartered in New York, USA focussed on developing proprietary ‘off-the-shelf’ allogenic cell therapies to cure cancer.
Funding and backers
Backers
1
SOSV
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
About Us Kamau Therapeutics is a clinical-stage, next-generation gene correction company harnessing high efficiency targeted gene…
TreeFrog Therapeutics develops transformative regenerative medicine at industrial scale, enabling cell therapies to treat millions of…
Is to address the patient unmet needs with our novel off-the-shelf, allogeneic Natural Killer T (NKT) cell therapies for the treatment of…
Arsenal Biosciences, Inc. is a clinical stage, programmable cell therapy company focused on solid tumor cell therapies to defeat cancer.
Imagine there is a cure for cancer but it is only accessible to a very small number of patients. This is what we want to change.
Advancing novel therapies to restore the health of gastrointestinal tissues. Curileum is developing novel therapies that restore the health…
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
SOSVVia a fund
777 portfolio companies
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely